Business / Finance

RSS

Endo Pharmaceuticals to acquire American Medical Systems

Endo Pharmaceuticals and American Medical Systems today that they have entered into a definitive agreement under which Endo will acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

11 Apr 2011

Sanofi-aventis acquires Genzyme

Sanofi-aventis announced today that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of sanofi-aventis.

11 Apr 2011

QAD and Strategic Information Group to host Southern California Life Sciences Executive Forum

QAD Inc., a leading provider of enterprise business software and services for global manufacturing companies and its partner, Strategic Information Group (Strategic), announced today they will host the Southern California Life Sciences Executive Forum on April 12, 2011.

8 Apr 2011

McKinley Infocapital to distribute Biofield Breast Diagnostic System in Korea

Biofield Corp. announced today that its 51% owned subsidiary, Sky Unicorn Holdings Ltd., has engaged McKinley Infocapital as its exclusive distributor in Korea for its flagship product, the Biofield Breast Diagnostic System (BDS). McKinley Infocapital, an international business consulting and investment management firm, has formed MacKay Life Sciences Korea to market and promote the BDS in Korea.

8 Apr 2011

Kaydon completes HAHN-Gasfedern acquisition

Kaydon Corporation today announced that it has completed the acquisition of all of the outstanding shares of HAHN-Gasfedern GmbH and related real estate and intangible property ("Hahn") from Ulrich Hahn e.K. pursuant to the definitive agreement announced on February 25, 2011.

8 Apr 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

BSD Medical Corporation, a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its second fiscal quarter ended February 28, 2011.

8 Apr 2011

Unity receives first order for new BD Italian Tablet press

Unity Management Group, Inc. is a Health Resource Company specializing in Physician, and Hospital Practice Management, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, and Equipment Distribution.

8 Apr 2011

Creekridge Capital reports record-breaking volume for first quarter 2011

Creekridge Capital LLC, a nationwide independent healthcare and technology vendor leasing company, announced record-breaking volume for first quarter 2011 that exceeds any previous first quarter volume throughout its history.

8 Apr 2011

The MED Group creates National Orthotics and Prosthetics Network

The MED Group, a Managed Health Care Associates, Inc. (MHA) company, and a leading group purchasing and business solutions company focused on Home Medical Equipment providers is pleased to announce the creation of The MED Group National Orthotics and Prosthetics Network. Tim Pederson (formerly of WestMed Rehab) has joined The MED Group and will be leading the development of The MED Group's National Orthotics & Prosthetics Network.

8 Apr 2011

Sangamo prices public offering of 6.7M shares of common stock

Sangamo BioSciences, Inc. today announced the pricing of its previously announced public offering of 6,700,000 shares of its common stock at a price to the public of $7.70 per share. The public offering is expected to close on or around Wednesday, April 13, 2011, subject to customary closing conditions.

8 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

HCP closes acquisition of HCR ManorCare facilities for $6.1 billion

HCP announced that it closed the acquisition of 334 post-acute, skilled nursing and assisted living facilities of HCR ManorCare for a total consideration of $6.1 billion in cash. In connection with the closing, HCP entered into a long-term triple-net master lease under which HCR ManorCare will continue to operate the facilities.

8 Apr 2011

Amgen acquires Bergamo, expands operations in Brazil

Amgen, the world's largest biotechnology company, announced today the expansion of its operations in Brazil, including the acquisition of Bergamo, a privately-held Brazilian pharmaceutical company.

8 Apr 2011

Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products

Impax Laboratories, Inc. today announced that it will collaborate with Banner Pharmacaps Inc. with respect to the supply and commercialization of two softgel capsule products.

8 Apr 2011

Idenix prices underwritten registered public offering of 18 million shares of common stock

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix.

8 Apr 2011

Idenix begins underwritten registered public offering of common stock

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has commenced an underwritten registered public offering of shares of its common stock. All of these shares are being sold by Idenix.

8 Apr 2011

Catalyst Health prices public offering of 5,500,000 shares of common stock

Catalyst Health Solutions, Inc. today announced the successful pricing of its public offering of 5,500,000 shares of common stock, consisting of 4,500,000 shares to be sold by the Company and 1,000,000 shares to be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., at a price of $53.00 per share.

8 Apr 2011

Alcon to merge with Novartis at its Annual General Meeting of Shareholders

Alcon, Inc. announced that its shareholders approved the merger of Alcon into Novartis AG at its Annual General Meeting of Shareholders.

8 Apr 2011

Rochester Medical acquires Laprolan

Rochester Medical Corporation today announced that it has now completed the previously announced purchase of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed retroactive to January 1, 2011.

8 Apr 2011